IRCT20191020045162N1
Recruiting
Phase 3
Investigating the effect of resveratrol on therapeutic outcomes of acute ischemic stroke patient receiving r-tPA
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Ischemic stroke.
- Sponsor
- Kermanshah University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?All of acute ischemic stroke patient reciving r\-tPA.
Exclusion Criteria
- •Pregnant patient
- •Patients who received r\-tPA more than 24 hours ago
- •Previous cerebral hemorrhage and previous stroke
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
Completed
Phase 2
Evaluation of the effects of Resveratrol Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid profile, blood glucose, Insulin Sensitivity, and Hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease.on Alcoholic Fatty Liver.Inflammatory liver disease, unspecifiedIRCT201202014010N7ational Nutrition and Food Technology Research Institute50
Recruiting
Phase 3
Resveratrol in multiple sclerosisMultiple Sclerosis.Multiple sclerosisIRCT20230315057731N1Ahvaz University of Medical Sciences60
Recruiting
Phase 3
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
Completed
Phase 3
Evaluation of the effects of resveratrol in patients with Covid ??Covid-19.COVID-19, virus identifiedIRCT20111119008129N13Boushehr University of Medical Sciences140